DiaSorin

Historical price data

DiaSorin is an Italian multinational company specializing in the development, manufacturing, and commercialization of in vitro diagnostic (IVD) testing solutions, with a core focus on immunodiagnostics. The company leverages its proprietary chemiluminescence technology through the LIAISON® platform to offer a comprehensive menu of automated assays for infectious diseases, endocrinology, and autoimmune disorders. As a publicly traded entity, DiaSorin has established a strong global presence, driven by strategic acquisitions like Luminex, and is dedicated to advancing personalized medicine through accurate and accessible diagnostic tools. Its mission centers on partnering science and automation to empower laboratories and improve patient outcomes worldwide.

Proprietary chemiluminescence immunoassay (CLIA) technology for automated analyzers (LIAISON® platform) and multiplex bead-based array technology (xMAP®) acquired from Luminex for simultaneous multi-analyte detection.

DiaSorin competes with large, diversified IVD players (Roche, Abbott, Siemens) and specialized firms (BioMérieux, Thermo Fisher). Its differentiation lies in its deep specialization in immunodiagnostics, a curated menu of high-value tests, and the unique combination of chemiluminescence and multiplex technologies post-Luminex acquisition.